Filter
856
Text search:
pharmaceutical
manufacturers
Featured
Recommendations
89
New Publications
197
Language
Document type
No document type
362
Studies & Reports
194
Guidelines
159
Manuals
63
Strategic & Response Plan
44
Fact sheets
13
Training Material
8
Situation Updates
7
Resource Platforms
3
Brochures
2
Infographics
1
Countries / Regions
Global
43
India
28
Kenya
27
Nigeria
23
Western and Central Europe
22
Ethiopia
19
South Africa
15
Uganda
11
Ukraine
11
Sierra Leone
10
Tanzania
10
Eastern Europe
10
Ghana
9
Philippines
9
Rwanda
9
Namibia
9
Latin America and the Carribbean
9
Zimbabwe
8
Malawi
8
Nepal
7
Africa
7
Liberia
6
Bangladesh
6
Eastern Europe and Central Asia
6
Zambia
5
Indonesia
5
Myanmar / Burma
5
South–East Asia Region
5
Senegal
4
Syria
4
Cambodia
4
Thailand
4
Botswana
4
West and Central Africa
4
Burkina Faso
3
Haiti
3
East and Southern Africa
3
Asia
3
Egypt
2
Sudan
2
Eswatini/ Swaziland
2
North Macedonia
2
Serbia
2
Middle East and North Africa
2
Western Pacific Region
2
Albania
2
Laos
2
Russia
2
Kyrgyzstan
2
Vietnam
2
North America
2
Jamaica
2
Congo, Democratic Republic of
1
Mali
1
USA
1
Cameroon
1
Somalia
1
Pakistan
1
South Sudan
1
Afghanistan
1
Germany
1
China
1
Mozambique
1
Papua New Guinea
1
Benin
1
Lesotho
1
Chile
1
Armenia
1
Mongolia
1
Timor Leste/ East Timor
1
Tajikistan
1
Bulgaria
1
Moldova
1
Iran
1
Uzbekistan
1
Australia
1
Kazakhstan
1
Georgia
1
Gabon
1
Turkmenistan
1
Denmark
1
Maldives
1
United Kingdom
1
Authors & Publishers
Publication Years
Category
Countries
264
Clinical Guidelines
88
Public Health
44
Key Resources
40
Pharmacy & Technologies
36
Women & Child Health
29
Capacity Building
7
Toolboxes
Pharmacy
114
AMR
105
COVID-19
61
TB
45
HIV
44
Mental Health
32
Rapid Response
29
NTDs
28
NCDs
19
Global Health Education
18
Planetary Health
18
Conflict
15
Malaria
14
2.0 Rapid Response
14
Caregiver
12
Health Financing Toolbox
12
Specific Hazards
7
Disability
6
Ebola & Marburg
5
Polio
5
Refugee
5
Zika
2
Cholera
1
Natural Hazards
1
Interim Guidance October 2022. This addendum addresses some of the methodological aspects of VE evaluations that have been learned during the past year, as well as those that have become relevant in the current epidemiological setting of the COVID-19 pandemic. For some of the COVID-19 vaccine method
...
Southern Med Review (2009)2;1:2-6
Fair global distribution of COVID-19 vaccines
recommended
MEDBOX Issue Brief no.9 ,1 Febr. 2021
Am. J. Trop. Med. Hyg., 106 (Suppl 5), 2022, pp. 56–60. Lymphatic filariasis (LF) is a parasitic disease that is a major cause of chronic disability in the developing world. According to the 2021–2030 road map for neglected tropical diseases (NTDs) published by the World Health Organization (WHO
...
Despite high regional demand for vaccines valued at over US$ 1 billion annually, Africa’s vaccine industry provides only 0.1% of global supply. Vaccine inequity and hoarding at the start of the pandemic, which resulted in delays in obtaining COVID-19 doses, stimulated new resolve to address future
...
The manufacturing process is one of the key steps where quality control is required to ensure quality of medicinal products, including herbal medicines. Good manufacturing practices (GMP) is one of the most important tools for this measure.
WHO Pharmacovigilance indicators: a practical manual for the assessment of pharmacovigilance systems
This manual provides a practical method for determining the pharmacovigilance indices. It is designed to be simple and can be understood by any worker in pharmacovigilance without formal training in monitoring and evaluation. Pharmacovigilance as a medical discipline is crucial in preventing medicin
...
Documentation of Best Practices and Bottlenecks to Program Implementation in Senegal
SUMMARY REPORT
Accessed at March 2014
PMPB/INS-GUIDE/02
• provide scientific information on the safety, efficacy, and quality control/ quality assurance of widely used medicinal plants, in order to facilitate their appropriate use in Member States;
• provide models to assist Member States in developing their own mono- graphs or formularies for these
...
Cervical intraepithelial neoplasia (CIN) is a premalignant lesion that may exist at any one of three stages: CIN1, CIN2, or CIN3. If left untreated, CIN2 or CIN3 (collectively referred to as CIN2+) can progress to cervical cancer. Instead of screening and diagnosis by the standard sequence of cytolo
...
• provide scientific information on the safety, efficacy, and quality control/ quality assurance of widely used medicinal plants, in order to facilitate their appropriate use in Member States;
• provide models to assist Member States in developing their own mono- graphs or formularies for these
...
Examination of the business behavior of Boehringer Ingelheim, Bayer and Baxter in India